Acceleron Pharma, Inc.

Q1 2019 13F Holders

Symbol
XLRN
CUSIP
00434H108
Type
Equity
Class
COM
Num filings
195
Total reported value, excl. options
$2.33 B
Manager Report Date Value ($000) Shares Option Type